Medipal Holdings Corp ADR (MAHLY)

Currency in USD
19.16
0.00(0.00%)
Closed·
MAHLY is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
18.7619.16
52 wk Range
15.3720.35
Key Statistics
Prev. Close
19.16
Open
18.76
Day's Range
18.76-19.16
52 wk Range
15.37-20.35
Volume
758
Average Volume (3m)
1.64K
1-Year Change
4.4711%
Book Value / Share
19.52
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MAHLY Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Holds more cash than debt on its balance sheet

Medipal Holdings Corp ADR News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Neutral
Moving Averages
Strong Buy

Earnings

Latest Release
Aug 05, 2026
EPS / Forecast
66,66 / --
Revenue / Forecast
989,5B / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 227.21%
Dividend Yield
-
Industry Median 2.30%
Annualised payout
-
5-Years Growth
-
Growth Streak

MAHLY Income Statement

Compare MAHLY to Peers and Sector

Metrics to compare
MAHLY
Peers
Sector
Relationship
P/E Ratio
12.8x14.3x−0.3x
PEG Ratio
0.820.290.00
Price/Book
0.9x1.1x2.6x
Price / LTM Sales
0.2x0.3x3.0x
Upside (Analyst Target)
-14.5%58.6%
Fair Value Upside
Unlock29.3%7.4%Unlock

MediPal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. The company engages in the manufacture and supply of medical drugs, medical devices, medical supplies, clinical test reagents, and medical equipment and materials; non-life insurance agency business; outsourcing of medical office administration services; research and development of preventive medicine and cutting-edge medical technologies; and construction of a medical materials database. It is also involved in the wholesale of cosmetics, daily necessities, and OTC pharmaceuticals; animal health products for companion animals; and food processing raw materials for agriculture, fisheries, and livestock. In addition, the company offers management and marketing support for insurance pharmacies; logistics contract; veterinary medicines and feed additives; and food processing raw materials, food ingredients, food additives, and chemical product materials. It serves hospitals, clinics, pharmacies, drugstores, home centers, convenience store, supermarkets, veterinary clinics, livestock and fisheries businesses, processed food manufacturers, and other medical facilities. The company was formerly known as Mediceo Paltac Holdings Co., Ltd. and changed its name to MediPal Holdings Corporation in October 2009. The company was founded in 1898 and is headquartered in Chuo, Japan.

Employees
13024

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
60,05M29,33%1,15B
Other Institutional Investors
47,98M23,44%919,28M
Public Companies & Retail Investors
96,67M47,23%1,85B
Total
204,7M100,00%3,92B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Silchester International Investors LLP12,62%25 827 300494 851
Silchester International Investors International Value Equity Trust5,43%11 120 000213 059

FAQ

What Is the Medipal ADR (MAHLY) Stock Price Today?

The Medipal ADR stock price today is 19,16 USD.

What Stock Exchange Does Medipal ADR Trade On?

Medipal ADR is listed and trades on the OTC Markets.

What Is the Stock Symbol for Medipal ADR?

The stock symbol for Medipal ADR is "MAHLY."

What Is the Medipal ADR Market Cap?

As of today, Medipal ADR market cap is 3,79B USD.

What Is Medipal ADR's Earnings Per Share (TTM)?

The Medipal ADR EPS (TTM) is 227,21.

From a Technical Analysis Perspective, Is MAHLY a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Medipal ADR Stock Split?

Medipal ADR has split 0 times.

How Many Employees Does Medipal ADR Have?

Medipal ADR has 13024 employees.

What is the current trading status of Medipal ADR (MAHLY)?

As of Oct 05, 2026, Medipal ADR (MAHLY) is trading at a price of 19,16 USD, with a previous close of 19,16 USD. The stock has fluctuated within a day range of 18,76 USD to 19,16 USD, while its 52-week range spans from 15,37 USD to 20,35 USD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.